Menu

Experience

Rena Kaminsky

    • Neurocrine Biosciences Enters Collaboration Agreement with Sosei Heptares 


    • Neurocrine Partners With Takeda to Address Psychiatric Disorders 


    • Zai Lab Product Commercialization Collaboration with Regeneron 


    • Fate Therapeutics Licensing and Platform Collaboration with Janssen Biotech 


    • Selecta Biosciences – $74 Million IPO 


    • FibroGen Closes Largest Biotech IPO in 12 Years 


    • NewLink Genetics Signs $1 Billion Deal with Genentech for Cancer Drug Research & Development 


    • MyoKardia Collaboration with Sanofi 


    • Two Independent Billion-Dollar Life Sciences Collaborations 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • FORMA Therapeutics $200M Strategic Collaboration Deal with Celgene